- Lobbying
- Lobbying by American Society of Addiction Medicine, Inc.
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Erik Fatemi | Prof Staff Senate Approps Cmte (Byrd, Inouye, Mikulski) |
Mark Mioduski | Prof Staff; House Approps Cmte (Obey) |
William Smith | Staff Director, House Approps Cmte; Deputy Staff Director, House Approps Cmte; Chief of Staff, Legislative Director, Senior Legislative Assist, House Member Office (Rogers); Staff Assistant, Senate Approps Cmte |
Laura Bozell | LA House Member Office (McCrery), Prof Staff Ways & Means Cmte (Camp) |
Christopher Sarley | Policy Coordinator, House Energy & Commerce Committee; Policy Director, Sr Legis Asst, House Member Office (Shimkus); Sr Legis Asst, Legislative Assistant, Legislative Correspondent, Staff Assistant, House Member Office (Hastert) |
James Richards | COS House Member Office (Pearce); Director IGA USDA; Appropriations Associate House Member Office (Skeen & Bonilla) |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Alcohol & Drug Abuse
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Alcohol & Drug Abuse
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Alcohol & Drug Abuse
Q4 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Alcohol & Drug Abuse
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Alcohol & Drug Abuse
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Alcohol & Drug Abuse
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Alcohol & Drug Abuse
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Alcohol & Drug Abuse
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Alcohol & Drug Abuse
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Alcohol & Drug Abuse
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Alcohol & Drug Abuse
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Alcohol & Drug Abuse
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Alcohol & Drug Abuse
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Alcohol & Drug Abuse
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Alcohol & Drug Abuse
Registration
Issue(s) they said they’d lobby about: Funding for programs to address substance abuse and authorization bills regarding the treatment of addiction.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate